Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Spherix Initiates Production Of Tagatose
Spherix has received its first full-scale production batch of cGMP (FDA Current Good Manufacturing Practice) D-tagatose, USP grade. Spherix will use the tagatose in the process of satisfying
Spherix has received its first full-scale production batch of cGMP (FDA Current Good Manufacturing Practice) D-tagatose, USP grade. Spherix will use the tagatose in the process of satisfying
Javelin Pharmaceuticals (Javelin) has completed open-label, multi-dose, multi-day, observational safety study of Dyloject in the US, and has announced that it has successfully met its objective. The company
Takeda’ investigational compound, TAK-536 has entered into phase-III clinical trials in Japan. TAK-536 is a novel angiotensin receptor blocker (ARB) that is meant to lower blood pressure by
Resolvyx has initiated the first human phase-I clinical trial, evaluating an oral resolvin therapeutic, RX-10001 in healthy volunteers. RX-10001 is a synthetic form of RvE1, a naturally occurring
Covance has initiated integrated radiolabeled clinical pharmacology studies, in compliance with FDA guidance on Metabolites in Safety Testing (MIST). Recent MIST guidance requires earlier human absorption, metabolism and
Laboratory Corporation of America and Monogram Biosciences have entered into an agreement and plan of merger. As per the agreement, LabCorp will acquire all of the outstanding shares
Baxter has signed a definitive agreement with Edwards Lifesciences to acquire certain assets related to Edwards’ hemofiltration product line, also known as Continuous Renal Replacement Therapy (CRRT). The
OctoPlus has started pharmaceutical production in its new manufacturing facility in Leiden. The facility has received a license from the Dutch authorities to manufacture pharmaceutical products, according to
Inaccurate test results may fail to indicate HIV in an infected individual, or indicate HIV when none is present. Under the Medical Devices Regulations, home HIV test kits
Emisphere and Syracuse University have entered into a research agreement to combine Emisphere’s Eligen oral drug delivery technology with a new oral drug delivery system developed in the